Table 3 Most cited papers (WoS dataset)
Title | Authors (year) | Journal | Citation count (global) |
|---|---|---|---|
The price of innovation: new estimates of drug development costs | [17] | Journal of Health Economics | 2,475 |
Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: Report of the ISPOR Task Force for Translation and Cultural Adaptation | [410] | Value in Health | 2,314 |
The estimation of a preference-based measure of health from the SF-36 | [89] | Journal of Health Economics | 2,051 |
The validity and reproducibility of a work productivity and activity impairment instrument | [411] | Pharmacoeconomics | 1,578 |
Measurement of health state utilities for economic appraisal - a review | Journal of Health Economics | 1,457 | |
Estimating log models: to transform or not to transform? | [133] | Journal of Health Economics | 1,515 |
Medication compliance and persistence: Terminology and definitions | [284] | Value in Health | 1,331 |
Innovation in the pharmaceutical industry: New estimates of R&D costs | [412] | Journal of Health Economics | 1,272 |
The Epidemiology of Obesity: A Big Picture | [413] | Pharmacoeconomics | 1,129 |
Conjoint Analysis Applications in Health-a Checklist: A Report of the ISPOR Good Research Practices for Conjoint Analysis Task Force | [172] | Value in Health | 907 |